Blum Holdings, Inc. (BLMH)
Blum Holdings, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Downey, CA, US. The stock last traded at $0.18, up 0.41% on the session, giving a market capitalisation of $2.4M. On trailing twelve-month figures it carries a trailing P/E of -0.40, a net margin of -62.2%. Its beta of 2.14 implies it has historically moved more than the broad market.
Blum Holdings, Inc. is an entity operating within California's regulated cannabis market, comprehensively addressing both medical and adult-use demands. The company's multifaceted involvement encompasses the cultivation, production, distribution, and retail sales of cannabis products. Its business activities are organized into two primary divisions: Cannabis Retail and Cannabis Distribution. This includes direct oversight of its cultivation sites, manufacturing facilities, and dispensaries catering to diverse customer needs. The company, originally established in 2010, maintains its principal office in Santa Ana, California. It adopted the name Blum Holdings, Inc. in January 2024, having previously operated as Unrivaled Brands, Inc.
Blum Holdings, Inc. is most often compared with the following Healthcare names: